Back to Archived Journals » Biosimilars » Volume 2
Biosimilars ceased publishing in October 2016. All new submissions can be made to Biologics: Targets and Therapy. All articles that have been published in Biosimilars will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
![](https://www.dovepress.com/cr_data/cache/journal_image/113/cope/thumb_100_1000_100.jpg)
Biosimilars
ISSN: 2230-245X
- View all (31)
- Volume 6, 2016 (6)
- Volume 5, 2015 (9)
- Volume 4, 2014 (4)
- Volume 3, 2013 (6)
- Volume 2, 2012 (4)
- Volume 1, 2011 (2)
Archive: Volume 2, 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A European perspective on the market accessibility of biosimilars
Declerck PJ, Simoens S
Biosimilars 2012, 2:33-40
Published Date: 16 November 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The development and introduction of biosimilar anticoagulants – focus on enoxaparin
Ginsberg JS
Biosimilars 2012, 2:27-31
Published Date: 13 September 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical efficacy and safety of HX575, a biosimilar recombinant human erythropoietin, in the management of anemia
Abraham I, MacDonald K
Biosimilars 2012, 2:13-25
Published Date: 6 September 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical appraisal of biosimilar filgrastim (Nivestim™) for febrile and chemotherapy-induced neutropenia
Waller CF
Biosimilars 2012, 2:1-11
Published Date: 20 August 2012